Luc Cabel

Luc Cabel

Institut Curie - Paris / France
Others
AD Scientific Index ID: 4475845
Curie Institute
person_outline Luc Cabel's MOST POPULAR ARTICLES
1-) Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept studyL Cabel, F Riva, V Servois, A Livartowski, C Daniel, A Rampanou, O Lantz, ...Annals of Oncology 28 (8), 1996-2001, 20172022017
2-) The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperM Cristofanilli, JY Pierga, J Reuben, A Rademaker, AA Davis, DJ Peeters, ...Critical reviews in oncology/hematology 134, 39-45, 20191902019
3-) Circulating tumor cells: clinical validity and utilityL Cabel, C Proudhon, H Gortais, D Loirat, F Coussy, JY Pierga, FC BidardInternational journal of clinical oncology 22 (3), 421-430, 20171882017
4-) Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapyL Cabel, C Proudhon, E Romano, N Girard, O Lantz, MH Stern, JY Pierga, ...Nature reviews Clinical oncology 15 (10), 639-650, 20181962018
5-) Clinical utility of circulating tumor cells: An updateA Vasseur, N Kiavue, FC Bidard, JY Pierga, L CabelMolecular oncology 15 (6), 1647-1666, 20211662021